Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical hold
Biotech
Regenxbio gene therapy refiling plan derailed by FDA hold
The FDA put a hold on RGX-121 over spine MRI findings, derailing the biotech’s plans to refile for approval of the once-rejected gene therapy.
Nick Paul Taylor
Aug 24, 2026 7:51am
After trimming headcount, Aardvark drops trials as wait drags on
Aug 12, 2026 9:03am
Aardvark to dig into phase 3 data early after FDA imposes hold
May 15, 2026 1:51am
FDA hits Newron schizophrenia ph. 3 trial with hold after death
Apr 29, 2026 2:50pm
Gilead cancels HIV trial as clinical hold remains intact
Apr 1, 2026 4:50pm
PepGen hit with partial hold, analyst blames 'understaffed FDA'
Mar 5, 2026 5:45am